ACQUIRED IMMUNE DEFICIENCY SYNDROME
ACQUIRED IMMUNE DEFICIENCY SYNDROME
批准号:
3877052
负责人:
A G PALESTINE
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AIDS Betaherpesvirinae Herpesviridae disease antiviral agents blindness child (0-11) dihydroxypropoxymethylguanine drug adverse effect eye disorder chemotherapy eye infections human immunodeficiency virus human immunodeficiency virus 1 human subject human therapy evaluation intravenous administration lasers medical complication ocular herpes phosphonate retinitis virus classification
中文摘要
艾滋病患者有出现严重眼部问题的风险,
英文摘要
Patients with AIDS are at risk of developing significant ocular problems,
some of which can lead to blindness. Left untreated, CMV retinitis is a
major cause of blindness in AIDS patients. We have looked at the effect of
the new antiviral drug foscarnet and determined its ability to inhibit
progression of the virus. We have also started investigating the usefulness
of adjunctive therapy with laser photocoagulation in preventing progression
of the disease.
In the course of our studies, we have also identified new manifestations of
known infectious agents in patients with AIDS, namely, HZV retinitis. In
conjunction with the Pediatric Branch of the National Cancer Institute, we
have been following about 125 children with symptomatic HIV to determine
the natural history of the disease and to determine the probability of
significant ocular disease in these children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENDOCRINE MODULATION OF IMMUNE-MEDIATED EYE DISEASE IN RATS
-
批准号:3965391
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
ENDOCRINE MODULATION OF IMMUNE-MEDIATED EYE DISEASE IN RATS
-
批准号:3898141
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
INTRAOCULAR CLASS II ANTIGEN EXPRESSION IN ENDOTOXIN-INDUCED UVEITIS
-
批准号:3898142
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
INTRAOCULAR CLASS II ANTIGEN EXPRESSION IN ENDOTOXIN-INDUCED UVEITIS
-
批准号:3918821
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
THE EFFECT OF BROMOCRIPTINE ON HUMAN UVEITIS
-
批准号:3941664
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
THE EFFECT OF BROMOCRIPTINE ON HUMAN UVEITIS
-
批准号:3965390
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
THE EFFECT OF BROMOCRIPTINE ON HUMAN UVEITIS
-
批准号:3918819
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
LYMPHOCYTE MIGRATION IN EXPERIMENTAL AUTOIMMUNE UVEITIS
-
批准号:3918817
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
LYMPHOCYTE MIGRATION IN EXPERIMENTAL AUTOIMMUNE UVEITIS
-
批准号:3898139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
LYMPHOCYTE MIGRATION IN EXPERIMENTAL AUTOIMMUNE UVEITIS
-
批准号:3941662
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
THE EFFECT OF BROMOCRIPTINE ON HUMAN UVEITIS
-
批准号:3898140
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
MODULATION OF RETINAL PERMEABILITY BY INFLAMMATORY MEDITORS
-
批准号:3898147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
LYMPHOCYTE MIGRATION IN EXPERIMENTAL AUTOIMMUNE UVEITIS
-
批准号:3965389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
AUTOIMMUNITY TO THE ANTERIOR UVEA IN PATIENTS WITH UVEITIS
-
批准号:3898152
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
ASSESSMENT OF THE SIZE OF THE LEAK INDUCED IN RETINAL VESSELS USING PITC-DEXTRANS
-
批准号:3941671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
INTRAOCULAR CLASS II ANTIGEN EXPRESSION IN ENDOTOXIN-INDUCED UVEITIS
-
批准号:3941665
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
AUTOIMMUNITY TO THE ANTERIOR UVEA IN PATIENTS WITH UVEITIS
-
批准号:3918840
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
ENDOCRINE MODULATION OF IMMUNE-MEDIATED EYE DISEASE IN RATS
-
批准号:3918820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
LYMPHOCYTE MIGRATION IN EXPERIMENTAL AUTOIMMUNE UVEITIS
-
批准号:4693375
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位:
ACQUIRED IMMUNE DEFICIIENCY SYNDROME
-
批准号:3918818
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A G PALESTINE
-
依托单位: